1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Humoral Hypercalcemia Of Malignancy: new trials by email Literature Review of Humoral Hypercalcemia Of Malignancy trials Research Report on Humoral Hypercalcemia Of Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM JMT103 - Hypercalcemia of Malignancy | Phase 1 / Phase 2 | Terminated | Shanghai JMT-Bio Inc. | 4 | 2020-04-22 | 2026-09-18 |
| One Week Comparison Study of PTH and PTHrP Infusions Parathyroid Hormone-related Protein (1-36), parathyroid hormone (1-34), PTH (1-34) and PTHrP (1-36) - Osteoporosis, Hypercalcemia of Malignancy | Phase 1 | Withdrawn | University of Pittsburgh | 2015-01-01 | 2014-12-05 | |
| Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases monoclonal antibody CAL, zoledronic acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 1 / Phase 2 | Completed | Chugai Pharmaceutical | 2002-11-01 | 2013-05-15 |
Bone Diseases, Endocrine (1) · Breast Neoplasms (1) · Endocrine System Diseases (1) · Hyperparathyroidism (1) · Musculoskeletal Diseases (1) · Neoplasm Metastasis (1) · Osteoporosis (1) · Pain (1)
Bone Diseases (1) · Bone Diseases, Metabolic (1) · Breast Diseases (1) · Metabolic Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Parathyroid Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
Antibodies, Monoclonal (1) · Parathyroid Hormone (1) · Parathyroid Hormone-Related Protein (1) · Zoledronic Acid (1) · parathyroid hormone-related peptide (1-36) (1)
Chugai Pharmaceutical (1) · Shanghai JMT-Bio Inc. (1) · University of Pittsburgh (1)
United States (2) · China (1)
Jin LI, PHD (1) · Mara J. Horwitz, MD (1) · Paula Silverman, MD (1)